MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.
Medical device titan Medtronic (NYSE:MDT) won gold, spending another month at the top of the internet chatter hierarchy for another month as CEO Omar Ishrak celebrated his 1-year anniversary and group purchasing organization Novation’s CEO looks back on last year’s split.
Johnson & Johnson (NYSE:JNJ) took silver with news of its latest quarterly earnings and CEO Alex Gorsky’s take on emerging markets.
Covidien (NYSE:COV) and St. Jude Medical (NYSE:STJ) followed behind with their own earnings reports as well as news of recalls and warnings on the cardiac rhythm management market. Boston Scientific (NYSE:BSX) rounded out the top 5 with a clutch of news on product approvals and a tragic slump in stock value following a difficult quarter.
Medtronic
- Medtronic’s Ishrak lands $25M in salary, benefits in 1st year – July 2
- Medtronic wins expanded FDA indication for snoring implant – July 12
- Medtronic CEO Omar Ishrak marks 1 year on the job with a Tweet – July 12
- Medtronic joins forces with NeuroLogica for surgical navigation – July 13
- Medtronic board member Jean-Pierre Rosso reaches “mandatory retirement age” – July 16
- Former Medtronic CEO nets $8M in comp package during 2012 – July 16
- Medtronic launches CoreValve trial – July 18
- Report: Is Medtronic looking to invest in India’s largest med-tech provider? – July 19
- EXCLUSIVE: Novation CEO looks back on Medtronic split – July 19
- Medtronic pain pump lawsuit: 9th circuit to rehear preemption win – July 27
- Medtronic wins 510(k) for latest surgical sealer – July 30
Johnson & Johnson
- U.K. regulators warn on counterfeit J&J surgical clips – July 11
- Johnson & Johnson lowers guidance after Q2 profits plunge 50% – July 17
- J&J’s Q2 medical device sales stay flat – July 17
- Johnson & Johnson CEO Gorsky: BRIC countries want to change healthcare delivery – July 24
Covidien
- FDA warns on Covidien’s liquid embolic system following 9 patient deaths – July 10
- Covidien issues 2nd U.K. warning on mobile ventilators over potential battery issues – July 12
- Covidien CEO Joe Almeida talks innovation, emerging markets – July 16
- Covidien’s Solitaire FR Revascularization Device Receives Regulatory Approval in Brazil – July 19
- Covidien sees growth in U.S., troubles in Europe – July 26
- FDA clears Covidien’s latest Nellcor continuous respiratory monitor – July 30
- Covidien makes a small round of job cuts connected to Newport buyout – July 31
St. Jude Medical
- University of Michigan sues St. Jude Medical for breach of contract – July 9
- St. Jude wins 510(k) for ViewFlex Xtra ultrasound catheter – July 10
- Riata failure rates in St. Jude’s probe in line with external data – July 16
- St. Jude’s first-to-market quadripolar defibrillator heads to Japan – July 17
- Pacemakers: St. Jude lowers earnings outlook, shares drop 6% – July 18
- St. Jude Medical CEO: The CRM market hasn’t hit bottom yet – July 18
- St. Jude CEO: Device tax will have “unintended consequences” – July 19
- St. Jude Medical recalls Eon, Eon Mini pain management implants on battery, charging issues – July 31
Boston Scientific
- Boston Scientific closes enrollment in Watchman trial – July 2
- BSX’s incoming CEO Mahoney on leaving J&J: “The opportunity was too good to pass up” – July 11
- Appeals court uphold Boston Scientific win in shareholders’ CRM suit – July 17
- Pain management: Boston Scientific joins Neuros Medical’s $3.5M funding round – July 18
- Boston Scientific earnings: CRM slump continues as BSX swings to a loss in Q2, lowers guidance for 2012 – July 26
- Wall Street: Boston Scientific shares hit lowest level in nearly 20 years – July 26
- TAVI: Boston Scientific says it will take longer, cost more to bring Lotus valve system to market – July 27
- Boston Scientific wins Euro nod for MRI-friendly pacemaker – July 30
